GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Molecular Partners AG (OTCPK:MLLCF) » Definitions » Pretax Margin %

MLLCF (Molecular Partners AG) Pretax Margin % : -2,408.33% (As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Molecular Partners AG Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Molecular Partners AG's Pre-Tax Income for the three months ended in Sep. 2024 was $-19.36 Mil. Molecular Partners AG's Revenue for the three months ended in Sep. 2024 was $0.80 Mil. Therefore, Molecular Partners AG's pretax margin for the quarter that ended in Sep. 2024 was -2,408.33%.

The historical rank and industry rank for Molecular Partners AG's Pretax Margin % or its related term are showing as below:

MLLCF' s Pretax Margin % Range Over the Past 10 Years
Min: -1042.84   Med: -152.5   Max: 62.17
Current: -1042.84


MLLCF's Pretax Margin % is ranked worse than
73.84% of 1013 companies
in the Biotechnology industry
Industry Median: -148.6 vs MLLCF: -1042.84

Molecular Partners AG Pretax Margin % Historical Data

The historical data trend for Molecular Partners AG's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Molecular Partners AG Pretax Margin % Chart

Molecular Partners AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -177.95 -671.81 -683.65 62.17 -880.73

Molecular Partners AG Quarterly Data
Jun19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -450.12 -1,917.18 -413.66 -972.56 -2,408.33

Competitive Comparison of Molecular Partners AG's Pretax Margin %

For the Biotechnology subindustry, Molecular Partners AG's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Molecular Partners AG's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Molecular Partners AG's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Molecular Partners AG's Pretax Margin % falls into.



Molecular Partners AG Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Molecular Partners AG's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-71.674/8.138
=-880.73 %

Molecular Partners AG's Pretax Margin for the quarter that ended in Sep. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=-19.363/0.804
=-2,408.33 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Molecular Partners AG  (OTCPK:MLLCF) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Molecular Partners AG Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Molecular Partners AG's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Molecular Partners AG Business Description

Traded in Other Exchanges
Address
Wagistrasse 14, Schlieren, Zurich, CHE, 8952
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.